Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 6, 2026
Development of anti-EGFR targeted magnetic nanoparticles for doxorubicin delivery into triple negative breast cancer cellsChloé Lameli, Stéphanie David, Emilie Allard-Vannier, et al.
International Journal of Biological Macromolecules|May 14, 2025
Increasing the developability of lambda chain antibodies: engineering to confer protein L binding activity and its consequencesBianca Prado-Costa, Gaëlle Dupeyrol, Fanny Boursin, et al.
International Journal of Biological Macromolecules|July 8, 2022
An effective strategy for the humanization of antibody fragments under an accelerated timelineIsabella Gizzi Jiacomini, Martina Beltramino, Fanny Boursin, et al.
Nanoscale|January 8, 2025
Metformin-encapsulating immunoliposomes conjugated with anti-TROP 2 antibody fragments for the active targeting of triple-negative breast cancerDaiva Vozgirdaite, Emilie Allard-Vannier, Florence Velge-Roussel, et al.
Pharmaceutics|July 27, 2022
Intra-Domain Cysteines (IDC), a New Strategy for the Development of Original Antibody Fragment-Drug Conjugates (FDCs)Louis Jolivet, Imène Ait Mohamed Amar, Catherine Horiot, et al.
Toxins|April 23, 2020
Loxoscelism: Advances and Challenges in the Design of Antibody Fragments with Therapeutic PotentialSabrina Karim-Silva, Alessandra Becker-Finco, Isabella Gizzi Jiacomini, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 12, 2023
The proteolytic airway environment associated with pneumonia acts as a barrier for treatment with anti-infective antibodiesTimothée Blin, Christelle Parent, Gabrielle Pichon, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 20, 2026
Hospital in-use evaluation of the physical, chemical and affinity stability of the antibody-drug conjugate trastuzumab deruxtecan (Enhertu®)Emmanuel Douez, Nicolas Joubert, Guillaume Gabant, et al.
Molecular Therapy. Oncology|April 16, 2025
Neospora caninum as delivery vehicle for anti-PD-L1 scFv-Fc: A novel approach for cancer immunotherapyClément Riviere, Muna Aljieli, Marie-Noëlle Mévélec, et al.
Virology|March 25, 2026
A spike-binding protein as a versatile tool to detect and inhibit transmissible gastroenteritis virusMantasha Khan, Nathalie Lejal, Fanny Boursin, et al.
Pageof 2